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Antipsychotic drugs are effective for the treatment
of schizophrenia. However, the functional conse-
quences and subcellular sites of their accumulation
in nervous tissue have remained elusive. Here, we
investigated the role of the weak-base antipsy-
chotics haloperidol, chlorpromazine, clozapine, and
risperidone in synaptic vesicle recycling. Using
multiple live-cell microscopic approaches and elec-
tron microscopy of rat hippocampal neurons as
well as in vivo microdialysis experiments in chroni-
cally treated rats, we demonstrate the accumulation
of the antipsychotic drugs in synaptic vesicles and
their release upon neuronal activity, leading to
a significant increase in extracellular drug concentra-
tions. The secreted drugs exerted an autoinhibitory
effect on vesicular exocytosis, which was promoted
by the inhibition of voltage-gated sodium channels
and depended on the stimulation intensity. Taken
together, these results indicate that accumulated
antipsychotic drugs recycle with synaptic vesicles
and have a use-dependent, autoinhibitory effect on
synaptic transmission.
INTRODUCTION
Schizophrenia is a common, chronic, and severemental disorder
in which the brain loses its ability to discern the relevancy and
origin of information, leading to misinterpretations, hallucina-
tions, and delusions (Freedman, 2003; Kapur, 2003). It is830 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.believed that schizophrenia is caused by defects in various
neurotransmitter systems (Lisman et al., 2008) and the combined
action of multiple genetic defects and environmental factors
(Harrison and Weinberger, 2005).
Typical antipsychotic drugs (APDs) such as haloperidol (HAL)
and atypical APDs such as risperidone (RSP) and clozapine
(CLO) are effective for treating the symptoms of schizophrenia.
These drugs share a common action at dopamine (DA) recep-
tors and also affect other neurotransmitter receptors (Lisman
et al., 2008; Strange, 2001). During treatment, APDs accumu-
late in all brain regions (Gemperle et al., 2003; Kornhuber
et al., 1999, 2006; Korpi et al., 1984; Tsuneizumi et al., 1992),
and it has been hypothesized that the slow development of
their full effect coincides with their tissue accumulation. The
accumulation of weak-base psychotropic drugs in acidic
organelles results from acidic trapping after intraluminal
protonation of these weak bases with pKa values near to
neutrality (de Duve et al., 1974; Schmalzing, 1988; Trapp
et al., 2008). In addition, membrane potential differences
could also drive the accumulation of cationic molecules in
electronegative compartments (Duvvuri et al., 2004). Our
current knowledge regarding the role of psychotropic drugs
in synaptic vesicle recycling is limited, and the functional
consequences of a hypothesized APD accumulation in
synaptic vesicles (Rayport and Sulzer, 1995) have remained
elusive. In the present study, we clarified the intravesicular
accumulation of APDs and its effects on synaptic trans-
mission. We show that the exocytic release of APDs from
synaptic vesicles increased extracellular concentrations in
freely moving rats and allowed them to inhibit synaptic trans-
mission in a use-dependent manner. This paper describes
the release and autoinhibitory action of APDs that accumulated
in synaptic vesicles.
Table 1. Predicted Physicochemical Properties and Accumulation Factors of the APDs Used and the Model Substance LTR
Substance
Log Kow









CPZ 5.2 2.1 9.41 19.7 123 0.55 67.7
RSP 2.9 0.2 7.89, 3.23 2.4 67.6 0.1 6.8
HAL 3.0 0.1 8.25 2.7 84.4 0.03 2.5
CLO 3.5 2.0, 0.6 7.14, 5.34 2.75 74.1 1.28 94.9
LTR 2.1 1.4 7.5 1.5 55.5 n.a. 2.8
APDs of different classes are weak bases and accumulate in synaptic vesicles as calculated using a cell model adapted from Trapp et al. (2008). When
present in therapeutic plasma concentrations in the extracellular space, the drugs accumulate to intravesicular concentrations in the low micromolar
range. Kow, octanol water partition coefficient; pKa, acid dissociation constant; SV, synaptic vesicle; n.a., not applicable.
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Accumulation of APDs in Synaptic Vesicles
The subcellular distribution and accumulation of nonfluorescent
APDs can be studied using fluorescent model substances with
similar physicochemical properties (Rayport and Sulzer, 1995;
Kornhuber et al., 2010), such as LysoTracker Red (LTR). When
assessed by a Fick-Nernst-Planck equation-based model
(Trapp et al., 2008), in which the parameters (such as the cyto-
solic and organelle diameters and the membrane potential)
were adjusted to fit hippocampal synapses and vesicles, the
accumulation of LTR was found to be similar to that of the four
APDs: chlorpromazine (CPZ), HAL, RSP, and CLO (Table 1).
When parting from therapeutic plasma concentrations, all of
the APDs (Baumann et al., 2004) as well as LTR reached micro-
molar intravesicular concentrations. Incubating hippocampal
neuronal cultures with 50 nM LTR resulted in a punctate fluores-
cence staining. Costaining with pH-dependent aSyt1-cypHer5
antibodies (Adie et al., 2002; Welzel et al., 2011), specific for
the acidic lumen of synaptic vesicles (see Figures S1A–S1D
available online), revealed correlated intravesicular fluorescence
in synaptic boutons (Figure S1D) and brighter uncolocalized
staining of other acidic compartments such as lysosomes (Fig-
ure 1A; colocalization analysis in Figures S1E and S1F). Ultra-
structural analysis of cultures stained with photoconverted LTR
confirmed accumulation in extrasynaptic organelles and
synaptic vesicles with FM dye photoconversion-like staining
(Figures 1B and S1B). Because of this low intrasynaptic volume
fraction of synaptic vesicles, synaptic boutons were stained less
prominently when compared with other acidic organelles. The
LTR fluorescence at synaptic loci corresponded to a concentra-
tion of 180 nM LTR in solution (Figure S2), which is an underes-
timate because a synapse’s volume comprises only part of the
total focal volume. According to our model calculations, the
addition of 50 nM LTR should result in an intravesicular concen-
tration of 2.8 mM, which agrees fairly well with the experimen-
tally determined vesicular concentrations of 2.2 mM (Figure S2B).
To probe the accumulation of APDs more directly, we next
tested the ability of APDs to displace the model substance
from synapses. This experimental approach has been used to
measure drug accumulation in lysosomes by Kornhuber et al.
(2010) and in acidic organelles by Rayport and Sulzer (1995).
As before, hippocampal neurons were incubated with 50 nM
LTR and stained with aSyt1-cypHer5 (Figure 1C). The fluores-cence of LTR-stained organelles decreased after the APD appli-
cation (Figure 1E). Quantification of LTR fluorescence at synaptic
sites after APD application revealed a dose-dependent fluores-
cence decrease (Figure 1D) that, in its amplitude, fitted the
displacement of LTR from synaptic vesicles. The decrease was
not explained by quenching of the dye by the APDs (Figure 1F)
and was not observed at synapses labeled with the spectrally
similar FM4-64 (Figures 1D and 1F).
Accumulation of APDs in Synaptic Vesicles Requires
an Acidic Intravesicular Environment
The accumulation of APDs is thought to depend mainly on the
low pH, but it could also be affected by electrical gradients. In
addition to LTR treatment, synapses were labeled with both
aSyt1-Oy488 (to quantify number of synaptic vesicles) and
aSyt1-cypHer5 as a control for vesicular pH (Figure 2A). Quanti-
fication of the cypHer5 fluorescence signal demonstrated the
efficient inhibition of vesicular acidification by 80 nM folimycin
(Groemer and Klingauf, 2007; Sankaranarayanan and Ryan,
2001). Similarly, LTR fluorescence was significantly reduced at
an increased intravesicular pH (Figures 2B and 2C). In contrast,
depolarization by increased extracellular K+ concentrations
(40mV) had no significant effect on synaptic LTR accumulation.
Results from fluorescence imaging were mirrored by those
obtained by model calculations (Figure 2D). Given that the
synaptic vesicle volume comprises only 5.4% of the synaptic
volume and that LTR also accumulates in the cytosol (Table 1),
the LTR signal is predicted to be reduced to 55% over the entire
synapse. This matches the experimentally obtained LTR fluores-
cence of 64.2% in the presence of folimycin reasonably well. We
conclude that the accumulation of APDs is a result of the low
intravesicular pH.
APD-Induced Displacement of LTR Is Not Due
to the Dissipation of Vesicular pH Gradients
The dissipation of vesicular pH gradients by APDs themselves
could contribute to the observed loss of LTR signal upon APD
application. To test this possibility, we performed experiments
with synaptopHluorin (spH), an optical probe consisting of
a pH-sensitive GFP coupled to the intravesicular domain of syn-
aptobrevin 2 (Miesenbo¨ck et al., 1998). First, we measured the
spH fluorescence increase following full deacidification of the
recycling pool to the external pH of 7.4 with folimycin. The spH
fluorescence increased by 48.6% ± 10.2% (data from WelzelNeuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 831
Figure 1. APDs Accumulate in Synaptic
Vesicles
(A) Representative images of living hippocampal
neurons. Left panel shows functional synapses
that are fluorescently labeled with anti-synapto-
tagmin1-cypHer5 (aSyt1-cypHer5). Middle panel
illustrates staining of the same region with 50 nM
LTR. Right panel presents overlay of aSyt1-
cypHer5 and LTR staining. LTR exhibits synaptic
and extrasynaptic fluorescence.
(B) Photoconversion electronmicroscopy image of
a hippocampal bouton labeled with LTR. Synaptic
vesicles (SV) and large extrasynaptic vesicle-like
structures (asterisk) are visible. Scale bar, 200 nm.
(C) Experimental procedure for (D) and (E). LTR
fluorescence intensity was determined before and
after the administration of APDs (‘‘Drug’’) to viable
LTR- and aSyt1-cypHer5-stained hippocampal
neurons.
(D) Representative images of hippocampal
neurons stained with 50 nM LTR or FM4-64 before
(Pre) and after (Post) the administration of the drug
or a vehicle (DMSO).
(E) Quantification of normalizedmean synaptic LTR
fluorescence intensity (n = 3 experiments each).
(F) Quantification of normalized (Norm.) fluores-
cence intensity of 1 mM LTR in saline and of FM4-
64-stained synapses after the addition of the indi-
cated substances (n = 3 experiments each). The
tested APDs did not quench but instead displaced
LTR from the synaptic terminals. Ctrl, control.
Error bars represent SEM. *p < 0.05, **p < 0.01,
t tests. Scale bars in (A) and (D), 5 mm.
Please see Figure S1.
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pH gradients was in accordance with the previously mentioned
reduction of LTR fluorescence by folimycin (Figures 2B and 2C).
Accordingly, if the LTR fluorescence loss of, e.g., 30% upon
application of HAL 5 mM (Figure 2) was from the dissipation of
vesicular pH gradients, then applying the drug would need to
increase the intravesicular spH fluorescence comparably to foli-
mycin. However, upon APD application only marginal differ-
ences in the spH fluorescence were observable, which were at
the detection limit of our camera system (Figures 2E, 2F, and
S3). The spH fluorescence, however, was very sensitive to small
NH4Cl-induced changes of the intravesicular pH (Figure 2E).
Thus, the dissipation of the vesicular pH gradient by APDs in
the concentrations used here is not a major factor contributing
to the loss of LTR fluorescence.
APDs Are Released from Synaptic Vesicles via
Exocytosis
Next, we tested whether accumulated weak bases can be
released from synaptic vesicles via exocytosis. Hippocampal
neurons stained with LTR and aSyt1-cypHer5 were electrically
stimulated with varying intensities (600 action potential-like
pulses [APs] at 30 Hz, 200 APs at 10 Hz, no Ca2+; Figure 3A).
We found that, as suggested previously by Schmalzing (1988),
electrical stimulation led to a decrease in the LTR fluorescence
at the synaptic sites, which depended on the presence of Ca2+832 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.and increased with the strength of the stimulus (Figure 3B).
TheCa2+ dependence, together with the fact thatmoderately de-
polarizing the cells with increased extracellular K+ concentration
did not significantly affect the accumulation of LTR in synaptic
vesicles (Figure 1), argues against a passive LTR release resulting
from the disruption of the electrical gradient across the synaptic
membrane. Moreover, the different amounts of dye that were
lost in response to varying stimulation intensities fit the expec-
tations of vesicular exocytosis (Figure 3C). Importantly, intense
LTR signals that did not colocalize with the synapse marker syn-
aptotagmin1 and might stain lysosomes or other acidic cellular
organelles did not show a decrease in fluorescence upon electri-
cal stimulation (Figure 3D), again arguing for the release of LTR
from synaptic vesicles via Ca2+-dependent exocytosis.
Activity-Dependent HAL and Transmitter Release
in Freely Moving Animals
To assess APD release after chronic treatment in vivo, we per-
formed microdialysis in freely moving rats, which was followed
by quantification of neurotransmitter and HAL. Animals were
implanted with osmotic minipumps, which delivered HAL
(0.5 mg/kg/d) for 14 days (Samaha et al., 2007), a dose that
was shown to provide a brain DA D2 receptor occupancy similar
to that required for human antipsychotic treatment action (Kapur
et al., 2003). On day 14, triple-probe microdialysis was per-
formed, measuring extracellular levels of HAL in the prefrontal
Figure 2. Acidic Intravesicular pH IsNeeded
for the Accumulation of APDs and Not
Changed by APD Treatment
(A) Experimental procedure. Rat hippocampal
neurons were stained with LTR in the presence or
absence of the vATPase inhibitor folimycin (Foli,
80 nM) with physiological (2.5 mM) or elevated
(10 mM) K+ levels. To simultaneously visualize
synapses and their acidification, the neurons were
coincubated with anti-Syt1-Oy488 (Oyster 488)
and an antibody with pH-dependent dye aSyt1-
cypHer5.
(B) Representative images of hippocampal
neurons stained as indicated in (A). Scale bar,
5 mm.
(C) Quantification of normalized (Norm.) mean
synaptic fluorescence intensity in the four different
staining paradigms (n = 3). Error bars represent
SEM.
(D) Normalized calculated LTR concentrations in
synaptic vesicles and whole synapses for folimy-
cin and K+ administration. The vesicle diameter,
number of vesicles, and synapse volume used
to calculate volume fractions were taken from
Schikorski and Stevens (1997).
(E) Upper panel shows average spH fluorescence
intensity profiles for the administration of ammo-
nium chloride (NH4Cl) (2.5 mM, n = 4, and 5.0 mM,
n = 5) and control (n = 4). Constant perfusion with
standard saline was switched to the vehicle or the
NH4Cl containing saline during minutes 4.5 and
9.0. Stim., electrical stimulation (50 AP, 10 Hz).
Lower panel presents average spH fluorescence
intensity profile. Cells were incubated with 80 nM
folimycin to dissipate the intravesicular pH
gradient of recycling vesicles. Stim., electrical
stimulation (1,200 AP).
(F) pH changes by administration of the different
APDs are limited to <0.1 pH. Baseline fluores-
cence levels and corresponding intravesicular
pH before (Pre) and during (Drug) administration
of substances. Indicated are DMSO (1:500), 5 mM
HAL, 5 mM CPZ, 10 mM CLO, 15 mM RSP,
2.5 mM and 5.0 mM NH4Cl (corresponding to a 0.4 and 0.7 pH change, respectively) and 80 nM folimycin (complete deacidification of the recycling pool of
vesicles to a pH of 7.5).
Error bars represent the SD. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant, t tests.
Please see Figures S2 and S3.
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Antipsychotic Drugs in Synaptic Vesicle Recyclingcortex (PFC) and the dorsal striatum (DStr) and extracellular
levels of DA and serotonin (5-HT) in the nucleus accumbens
(NAc), as a reference for transmitter release (Figure 3E) (Amato
et al., 2011). Baseline levels of HAL were 143.9 + 28.4 pg/ml in
the PFC and 179.1 + 40.5 pg/ml in the DStr (n = 5), which was
not corrected for recovery (in vitro, 84.7%). A 100 mM K+ chal-
lenge, applied locally by reverse dialysis (Chen and Kandasamy,
1996), significantly increased the extracellular HAL concentra-
tions compared to the baseline in the PFC (40 min samples,
samples S3 and S4 versus baseline; p < 0.05) and DStr (40 min
samples, samples S3 and S4, versus baseline; p < 0.05) during
the K+ challenge (Figure 3F). This was paralleled by an increase
in extracellular DA (20 min samples, samples S5–S8, versus
baseline; p < 0.05) and 5-HT levels (20 min samples, samples
S5 and S6, versus baseline; p < 0.05) (Figure 3G). These data
suggest that the extracellular HAL concentration in the brain isactivity dependent after chronic HAL treatment in freely moving
animals. It behaves similarly to the neurotransmitters DA and
5-HT. The different amounts of secreted HAL might reflect
varying accumulation, release, or even receptor distribution
properties, depending on the brain region. The activity-depen-
dent increase of HAL concentrations in the dialysate from the
synaptic cleft supports the idea of transient high APD concentra-
tions, especially in close proximity to the vesicle fusion sites after
synaptic vesicle fusion and APD release. It should be noted that
the absolute values reported here must be evaluated cautiously,
while the increases, in general, fit well with the findings in primary
cultures.
APDs Inhibit Synaptic Vesicle Exocytosis
To analyze the functional consequences of APD application on
synaptic vesicle recycling, we used rat hippocampal neuronsNeuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 833
Figure 3. APDs Are Secreted from Presynaptic Terminals during Activity
(A) Scheme of the experimental procedure. The LTR fluorescence intensity was determined before, during, and after the electrical stimulation of LTR- and aSyt1-
cypHer5-stained hippocampal neurons.
(B) Normalized LTR fluorescence intensity at synaptic sites over time. Electrical stimulation was performed in the presence (200 AP, 10 Hz and 600 AP, 30 Hz) or
absence (0 mM Ca2+, 600 AP, 30 Hz) of calcium ions. LTR is released by electrical stimulation in a calcium-dependent manner.
(C) Pie plot of the LTR fluorescence fractions at synaptic sites. A 20% or 25% dye loss would correspond to the release of 30% or 37% of the vesicular fluo-
rescence, respectively.
(D) Representative images of LTR-stained organelles that colocalize (arrowheads) or do not colocalize (triangles) with synaptic sites, as defined by aSyt1-cypHer5
before (F0) and after (F600AP) electrical stimulation. Synaptic (aSyt1-positive) and nonsynaptic (aSyt1-negative) LTR fluorescence intensities are indicated over
time. LTR is released from aSyt1-cypHer5-positive sites.
(E) In vivo microdialysis experiments in freely moving rats that were chronically treated with HAL (0.5 mg/kg/d) by osmotic minipumps were performed in various
brain regions: light blue indicates prefrontal cortex (PFC), red shows nucleus accumbens (Nac), and dark blue represents dorsal striatum (DStr).
(F) Extracellular HAL concentration (mean + SEM) after a local 100 mM K+ challenge administered by reverse dialysis (gray bar) in the PFC and DStr.
(G) Extracellular concentration of DA and 5-HT in the NAc (n = 5 experiments).
Error bars represent the SD. *p < 0.05, t tests versus last baseline sample.
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Antipsychotic Drugs in Synaptic Vesicle Recyclingtransfected with spH, an established reporter of exo- and
endocytosis (Figure 4A) (Sankaranarayanan et al., 2000). Our
experimental setup consisted of 18 electrical stimulations834 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.with 50 AP (10 Hz) every 1.5 min. During min 6–18 of the exper-
iment, the cells were perfused with either APDs or vehicle
(Figure 4B).
Figure 4. CPZ, HAL, CLO, and RSP Reversibly Reduce Synaptic Vesicle Exocytosis in a Dose-Dependent Manner, as Measured with spH
(A) Image details of rat hippocampal neurons transfected with spH in a representative experiment. The intensity (in arbitrary units) is indicated by color maps. (a)
Initial fluorescence intensity (F0). Scale bar, 5 mm. (b) Fluorescence intensity reached after electrical stimulation with 50 action potentials (AP) at 10 Hz (F50AP). (c)
Difference image of (a) and (b) (dF). (d) Automatically detected regions of interest (ROI) marked by white circles. (e) spH time course upon electrical stimulation
with a scheme of the calculated parameters. The relative spH amplitudes are normalized to the dF values.
(B) Fluorescence time course in representative experiments. Average fluorescence intensity profiles for the administration of the vehicle (DMSO, 1:1,000, n = 5)
and of 5 mMHAL (n = 5). Constant perfusion with standard saline was switched to the vehicle or the drug containing saline during min 6–18. Stimulation, electrical
stimulation (50 AP, 10 Hz).
(C) Time courses showing themean normalized evoked spH fluorescence increase with themaximal concentration-dependent amplitude reduction relative to the
vehicle control (column plots) (n = 5 or 6, n > 120). ANOVA: CPZ, F4,103 = 193.92, p < 0.001; HAL, F5,126 = 180.30, p < 0.001; CLO, F2,65 = 20.67, p < 0.001; RSP,
F3,80 = 49.81, p < 0.001. Error bars represent SEM. **p < 0.01, ***p < 0.001, t tests.
See Figure S4.
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exocytosis fluorescence responses upon administration of
APDs in contrast to vehicle control (Figure 4C). This reduction
was reversible for all four APDs. Compensatory endocytosis of
synaptic vesicles was not affected by HAL, CPZ, CLO, and
RSP (Figure S4). We conclude that APDs inhibit electricallystimulated synaptic vesicle exocytosis in a dose-dependent
manner.
APDs Reduce Presynaptic Calcium Transients
Action potential propagation along the axon results in the influx
of Ca2+ through voltage-gated ion channels into synapticNeuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 835
Figure 5. APD-Induced Inhibition of Exocytosis
Correlates with a Reduction in Stimulation-Depen-
dent Ca2+ Entry
(A) Image details of fluo-4- and FM5-95-stained rat
hippocampal neurons in a representative experiment.
Scale bar, 5 mm. Intensity scales are indicated for every
image. (a) Initial fluorescence intensity of fluo-4-stained
cells. Scale bar, 5 mm. (b) Electrical stimulation with 50
action potentials (AP) at 10 Hz provokes a Ca2+ influx that
leads to an increase in fluo-4 fluorescence. (c) Staining
with FM5-95. (d) FM5-95 is unloaded by electrical stimu-
lation with 600 AP at 30 Hz. (e) The difference image
between (c) and (d) enables the localization of the synaptic
boutons. Automatically detected regions of interest (ROIs)
aremarked bywhite circles. (f) The ROIs defined in (e) were
used for the fluo-4 analysis.
(B) Average fluorescence intensity profiles for the vehicle
(DMSO, 1:1,000) and HAL (10 mM). Synaptic regions were
identified by FM5-95 (Ac–Af, Ba, Bb). Subsequent fluo-4
imaging allowed for repetitive measurements of evoked
synaptic Ca2+ transients (Aa, Ab, Af, Bb, Bc). Constant
perfusion with standard saline was switched to either the
vehicle or the drug containing saline between min 4.5 and
9. Stim., electrical stimulation (600 AP, 30 Hz for FM5-95
and 50 AP, 10 Hz for fluo-4).
(C) Normalized average fluorescence intensity profiles of
spH and fluo-4. Vehicle (VEH, 1:500), CPZ (10 mM), HAL
(10 mM), CLO (20 mM), RSP (30 mM). Scale, 1.0 versus 1min
(n = 5, n > 200 for spH; n = 5 or 6, n > 900 for fluo-4).
(D) Mean spH and fluo-4 amplitude reductions relative to
the vehicle control during the perfusion of the indicated
drug (‘‘Drug’’) or after the perfusion of the drug (‘‘Post
drug’’). *p < 0.05, **p < 0.01, ***p < 0.001.
(E) Correlation of the relative fluorescence increase by spH
exocytosis and fluo-4-indicated Ca2+ influx in the APD and
control experiments. The inhibition of Ca2+ entry correlates
with the inhibition of synaptic vesicle exocytosis (n = 5,
R = 0.86; p < 0.001). Values are taken from the experi-
ments depicted in (C). Dotted line shows linear regression
(y = ax). p Value is for the hypothesis a = 0. Error bars
represent SEM.
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Because APDs have been described to have diverse effects on
the ion channels involved in this process (Ogata et al., 1989;
Sah and Bean, 1994; Wakamori et al., 1989; Yang and Wang,
2005), we next tested whether the observed inhibition of exocy-
tosis is directly linked to ion channel modulation or is the result of
effects on the multitude of proteins involved in the assembly and
function of the presynaptic vesicle release machinery itself.
We first analyzed the role of calcium channels because Ca2+ is
directly linked to vesicle release via the Ca2+-sensor synaptotag-
min. We measured stimulation-dependent changes in fluo-4-
fluorescence while blocking postsynaptic Ca2+ influx by AP5
(Koester and Johnston, 2005; Oertner et al., 2002; Schiller
et al., 1998). Fluo-4 showed a strong fluorescence increase
upon electrical stimulation and Ca2+ influx (Figure 5A) (Gee
et al., 2000). Synaptic boutons were identified by their activity-
dependent FM styryl dye uptake and release (Groemer and Klin-
gauf, 2007), and fluo-4 fluorescence was quantified in these
regions (Figure 5A). Similar to the spH experiments (Figure 4),
the vehicle control did not alter the presynaptic Ca2+ influx836 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.evoked by subsequent trains of 50 AP, whereas CPZ, HAL,
CLO, and RSP significantly reduced the Ca2+ influx (Figures
5B–5D). This inhibition of Ca2+ influx was reversible upon drug
washout for all of the APDs (Figures 5C and 5D). When
comparing the APD-induced amplitude reductions in the evoked
fluo-4 and spH fluorescence increases, we found a strong posi-
tive correlation (Figure 5E) (R = 0.86; p < 0.001) between the two
parameters. Thus, the inhibition of presynaptic Ca2+ influx corre-
lated strongly with the inhibition of synaptic vesicle exocytosis
for all of the APDs.
Although this result allowed us to conclude that no molecular
target within the synaptic vesicle releasemachinery is involved in
the mediation of the APD effect, the reduced Ca2+ influx is not
sufficient evidence to conclude that calciumchannels are a direct
target of APDs.
Presynaptic Inhibition of Synaptic Transmission
by APDs Is a Result of Sodium Channel Inhibition
Upstream of the Ca2+ influx, an APD effect on sodium channels
might be responsible for the reduced neurotransmitter release
Figure 6. APDs Inhibit SodiumChannels in a State-
and Use-Dependent Fashion
(A) Electrical stimulation requires signal propagation along
the axon to achieve synaptic transmission and is inhibited
by the application of TTX. Chemical stimulation with
40 mM K+, 20 s (comparable spH amplitude as evoked by
200 AP, 10 Hz) under 1 mM TTX was used to selectively
stimulate presynaptic terminals independent of sodium
channel action.
(B) Synaptic vesicle exocytosis was reported by spH and
monitored before and after drug administration. One
micromolar TTX completely blocked vesicular release by
electrical stimulation (200 AP 10 Hz). The chemically
induced exocytosis was insensitive to TTX and HAL
application. ***p < 0.001; n.s., not significant; t tests.
(C) Dose-response curves for HAL block of endogenous
(Nav1.1/Nav1.2) and Nav1.6r current in N1E115 neuro-
blastoma cells were determined from steady-state
recordings using the activation protocol depicted as inset
(Vh 90mV).
(D) Steady-state activation curves were constructed from
the activation protocol of (A) and the inactivation protocol
(depicted as an inset) before and during the application of
HAL (25 mM). Data points were fitted with the use of
a Boltzmann equation. Half-activation potential Vmid was
13.8 ± 1.4mV (Nav1.6r), 13.6 ± 1.0mV (Nav1.6r plus
HAL), 8.9 ± 1.1mV (Nav1.1/Nav1.2), and 10.7 ± 1.0mV
(Nav1.1/Nav1.2 plus HAL), with p = 0.004 for control versus
25 mM HAL in Nav1.1/Nav1.2. Half-inactivation potential
Vmid was61.4 ± 1.1mV (Nav1.6r),79.3 ± 1.4mV (Nav1.6r
plus HAL), 61.9 ± 1.7mV (Nav1.1/Nav1.2), and 72.6 ±
2.2mV (Nav1.1/Nav1.2 plus HAL), with p = 8.9E-6 for
control versus 25 mM HAL for Nav1.6r and p = 1.0E-5 for
control versus 25 mM HAL for Nav1.1/Nav1.2. There was
p = 0.002 for a HAL-induced voltage shift of Nav1.6r versus
Nav1.1/Nav1.2 (n = 8 for Nav1.6r, n = 7 for Nav1.1/Nav1.2).
(E) A gradual recovery from inactivation in a double-pulse
protocol with an increasing interpulse interval (inset) is
shown here for the endogenous current under the control conditions. The test pulse duration was 5 ms. The intervals between test pulses (Dt) are denoted above
the peak of the second current response.
(F) Plot summarizing the effect of HAL (25 mM) on the recovery from inactivation. The peak current elicited by the second pulse was normalized to the
peak current of the first pulse. The data points were fitted using a biexponential function and were plotted against the interpulse interval. Here, n = 3 for Nav1.6r
and n = 3 for Nav1.1/Nav1.2, at 20 ms. Additionally, p = 0.029 for control versus 25 mM HAL for Nav1.1/Nav1.2, and p = 0.04 for control versus 25 mM HAL
for Nav1.6r.
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their modulation by APDs (Ogata et al., 1989).
Thus, we first designed optical experiments to analyze the
contribution of sodium channel inhibition by the APDs on vesicle
exocytosis. Hippocampal neurons were stimulated either electri-
cally with 200 AP, 10 Hz, or chemically with 40 mM K+, 20 s, and
1 mM TTX (Figure 6A), which can evoke exocytosis by directly
depolarizing the presynaptic terminals in an action potential-
independent manner. Both of the stimulation paradigms led to
a marked increase in spH fluorescence with comparable ampli-
tudes. An application of the sodium channel blocker TTX (1 mM)
almost completely diminished the signal that was evoked by
electrical stimulation (Figure 6B). If sodium channels were
involved in the inhibition of vesicular exocytosis by APDs, then
the exocytosis signal from a high potassium application should
not be depressed by APDs. Indeed, the spH amplitude in
response to a high potassium application was not significantly
reduced upon application of 5 mMHAL (Figure 6B), which pointsto voltage-gated sodium channels as the primary presynaptic
target for APD action.
State- and Use-Dependent Inhibition of Sodium
Channels by HAL
We next performed experiments with N1E115 neuroblastoma
cells, which generate an endogenous sodium current mediated
by TTX-sensitive Nav1.1 and Nav1.2 sodium channels. We trans-
fected the N1E115 cells with a TTX-resistant Nav1.6 mutant and
recorded sodium currents during the application of HAL (0.25–
125 mM). By adding TTX to the bathing solution, we could distin-
guish the effects of HAL on the endogenous current mediated by
Nav1.1 and Nav1.2 from current solely carried by Nav1.6.
Axons in the central nervous system have been shown to
express all three voltage-dependent sodium channel isoforms
studied here, with a clear preponderance of Nav1.2 and
Nav1.6 (Lorincz and Nusser, 2008). Because the activation
threshold of Nav1.6 is considerably lower than that of Nav1.2,Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 837
Neuron
Antipsychotic Drugs in Synaptic Vesicle RecyclingNav1.6 was assigned the role of axonal ‘‘detonator,’’ triggering
impulse generation and conduction (Hu et al., 2009; Royeck
et al., 2008).
In the first set of experiments, we determined dose-response
relationships for the inhibitory action of HAL on the endogenous
sodium current and Nav1.6 using a standard activation protocol
(Figure 6C, inset). From the dose-response curves depicted in
Figure 6C, we calculated that half-maximal inhibition (IC50) of
the peak sodium current occurred at 13.1 ± 2.1 mM and 10.2 ±
4.0 mM for Nav1.1/Nav1.2 and Nav1.6, respectively. We then
examined the effect of 25 mM HAL on their steady-state activa-
tion and inactivation. HAL produced a small but significant left-
ward shift of the activation curve of the endogenous sodium
current, whereas Nav1.6 activation remained unaffected. In
contrast, HAL produced a much more pronounced shift of
steady-state inactivation to more negative potentials for both
endogenous current and Nav1.6 (Figure 6D). The leftward
shift of inactivation strongly suggested a preferential binding
of HAL to inactivated sodium channels. We calculated
(see Supplemental Experimental Procedures) Ki values to be
1.5 mM for Nav1.1/Nav1.2 and 0.18 mM for NaV1.6. These findings
indicate that HAL shows a pronounced state-dependent
binding, with its affinity to the inactivated state one (Nav1.1/
Nav1.2) or even two orders of magnitude (Nav1.6) higher
than to the resting state. The preferential binding of HAL to inac-
tivated Nav1.6 is of particular functional significance, given the
pivotal role of this Nav isoform in controlling the axonal
excitability.
We next investigated the use dependence of the HAL block by
measuring the gradual recovery of the peak sodium current from
inactivation in a double-pulse protocol, in which the interpulse
interval was increased stepwise (Figure 6E). Under control
conditions, endogenous currents and Nav1.6 completely recov-
eredwithin approximately 20ms. In the presence of HAL (25 mM),
however, both currents exhibited a slower and incomplete
recovery (Figure 6F). Together, our data indicate that HAL
inhibits high-threshold as well as low-threshold sodium channels
of central nervous system axons in a highly state- and use-
dependent fashion at concentrations that are well within the
therapeutic range.
The Degree of Inhibition of Synaptic Vesicle Exocytosis
Is Stimulation Dependent
The use-dependent inhibition of sodium channels should result
in a use-dependent inhibition of synaptic vesicle exocytosis.
To test this hypothesis, we quantified the inhibition of exocytosis
with HAL under weak (60 AP, 40 Hz) and more intense (180 AP,
40Hz) stimulation conditions bymonitoring the spH fluorescence
response of cultured hippocampal neurons to two identical
electrical stimulations 5 min apart. The second stimulus was
applied in the presence of the drug or vehicle (Figure 7A). Indeed,
increasing the number of APs from 60 to 180 significantly
increased the relative inhibition of exocytosis by 5 mM HAL
and enabled 0.5 mM HAL to significantly inhibit exocytosis
(Figure 7B).
To provide further evidence for an activity-dependent inhibi-
tion of exocytosis in the context of preserved neuronal networks,
we performed electrophysiological whole-cell recordings from838 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.visually identified neurons in hippocampal and NAc slices. Func-
tional consequences of a use-dependent sodium channel inhibi-
tion were assessed by applying stimulus trains. Excitatory post-
synaptic currents (EPSCs) of hippocampal CA1 pyramidal
neurons weremeasured during a 25 Hz stimulus train of 4 s dura-
tion in the absence and presence of two concentrations of HAL
(0.5 and 5 mM). Under control conditions, the stimulus train
produced an initial increase of the EPSC amplitude, which slowly
decayed and approached baseline toward the end of the train
(Figures 7C and 7D). The initial rise was also observed in HAL,
but EPSCs declined soon below baseline in a dose-dependent
fashion (Figures 7C and 7D). The progressive reduction of
EPSCs during the train reflects the use dependence of the
APD effect and is in line with the fluorescence measurements
presented in Figure 7B.
We used two strategies to substantiate our concept that the
use-dependent inhibition of EPSC is causally linked to the
blockade of voltage-gated sodium channels (Figure 6). First,
we demonstrated that the effects of HAL on train-evoked EPSCs
could be mimicked by a low concentration of the highly potent
and selective sodium channel blocker TTX (25 nM, Figures 7C
and 7D). Second, we functionally isolated axonal action poten-
tials and recorded their extracellular equivalent, the so-called
fiber volleys (FVs), in the absence and presence of either a low
concentration of TTX or several APDs. Under control conditions,
FVs exhibited only a small decrement later in the train. In sharp
contrast, TTX, which is known to block sodium channels in
a use-dependent manner (Conti et al., 1996) as well as all of
the three APDs tested (5 mM HAL, 30 mM CPZ, 30 mM RSP),
produced a pronounced use-dependent inhibition of FVs (Fig-
ure 7E). The depressant effect of APDs on EPSCs during train
stimulation is, therefore, sufficiently explained by their inhibitory
action on axonal action potentials.
Notably, the effect was not limited to the hippocampus but
was also observed in the NAc, which is a major target region
of dopaminergic projections and contains mainly medium
spiny neurons expressing D1 or D2 DA receptors. The behavior
of EPSCs in NAc medium spiny interneurons during stimulus
trains was remarkably different from that in hippocampal
CA1 pyramidal cells because, even under control conditions,
EPSCs displayed only a brief and weak initial enhancement
before they progressively decayed (Figures 7F and 7G). As
a consequence, the inhibitory effect of HAL (5 mM) was
much more pronounced when compared to the hippocampus
(Figures 7F and 7G). Importantly, FVs in NAc proved to be
approximately equally resistant to stimulus trains compared
with hippocampal FVs, and HAL reduced FVs with similar effi-
cacy (Figure 7H). These data indicate that, in the NAc with its
dense dopaminergic innervation, transmitter release is espe-
cially sensitive to the use-dependent inhibition of axonal sodium
channels by APDs.
Effective Inhibition of Exocytosis Requires the
Accumulation of APDs in Synaptic Vesicles
To determine whether the accumulation of APDs in synaptic
vesicles is required for the efficient inhibition of exocytosis, we
assessed the extent of the inhibition induced by 5 mM HAL in
the presence of folimycin, which abolished the accumulation of
Figure 7. The Inhibition of Synaptic Transmission by APDs Is Use Dependent
(A) Experimental procedure for the optical measurement of use-dependent inhibition. spH-reported electrically induced exocytosis was monitored before and
after drug administration.
(B) The ratio of spH fluorescence increases before and after the administration of HAL (0.5 or 5 mM), which was evoked with either 60 or 180 action potentials (AP)
at 40 Hz (n = 3 to 6, n > 120). Error bars represent SEM. *p < 0.05, **p < 0.01, n.s. not significant, t tests.
(C and D) The incubation of hippocampal slices with HAL (0.5 and 5 mM) for 2–5 hr dramatically enhanced the use-dependent reduction of EPSC amplitudes
(vehicle, n = 5; HAL 0.5 mM, n = 6; HAL 5 mM, n = 5) during 100 stimuli at 25 Hz. This effect wasmimicked by low-dose TTX (25 nM, 2–4 hr incubation, n = 5). EPSCs
were normalized to their amplitudes before the train. Illustrations in (C) are typical traces from different experiments. Insets depict superimposed EPSCs before
and 2 s after the start of a 25 Hz train with and without HAL incubation.
(E) Incubation of hippocampal slices (for 2–5 hr) with HAL (5 mM, n = 7), CPZ (30 mM, n = 5), RSP (30 mM, n = 5), and TTX (25 nM, n = 5) reduced CA1 axonal activity
during a 25 Hz train (vehicle n = 11). CA1 FVs were normalized to their amplitudes before the train. Insets depict superimposed FVs before and 2 s after the start of
a 25 Hz train.
(F and G) Incubation of slices containing NAc with HAL (5 mM) for 2–6 hr dramatically enhanced the use-dependent inhibition of EPSCs (vehicle, n = 8; HAL 5 mM,
n = 7) during 100 stimuli at 25 Hz. Insets depict superimposed EPSCs before and 1 s after the start of a 25 Hz train with and without HAL incubation.
(H) Incubation of NAc slices with HAL (5 mM) for 2–6 hr reduced axonal activity (vehicle, n = 6; HAL 5 mM, n = 6) during 100 stimuli at 25 Hz. Insets depict su-
perimposed FVs before and 1 s after the start of a 25 Hz train.
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with FM4-64 (Figure 8A). The fluorescence of the dye was unaf-
fected by changes of the intravesicular pH value (Figure 2B) or byAPD administration (Figure 2D). As expected, 5 mMHAL inhibited
the FM4-64 release that occurred in response to stimulation with
600 AP at 30 Hz (Figures 8B and 8C). However, in the presenceNeuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 839
Figure 8. Folimycin Prevents the Efficient Inhibi-
tion of Synaptic Vesicle Exocytosis and Calcium
Influx by HAL
(A) Experimental procedure for (B) and (C). The destaining
of FM4-64-loaded synaptic terminals by 600 AP at 30 Hz
was monitored in the presence of either the vehicle
(DMSO), HAL (5 mM) or HAL and folimycin (Foli+HAL,
80 nM folimycin and 5 mM HAL).
(B) Normalized fluorescence intensities of FM4-64-stained
hippocampal boutons as a function of time.
(C) Normalized DF before and after electrical stimulation
(n = 4 experiments, n > 150 synapses). Error bars repre-
sent SEM. *p < 0.05, ***p < 0.001, t tests.
(D) Image details of fluo-4-stained rat hippocampal
neurons from representative experiments. Scale bars,
5 mm. Upper panel illustrates that the DF (pre) of fluo4
induced by electrical stimulation with 50 AP at 10 Hz was
reduced in the presence of 10 mM HAL (DF drug). Lower
panel shows that in the presence of 80 nM folimycin,
the HAL-induced inhibition of calcium influx was less
pronounced.
(E) Normalized average fluorescence intensity profiles of
fluo-4 experiments. Vehicle (DMSO, 1:500), folimycin (Foli,
80 nM), HAL (10 mM), and folimycin plus HAL (Foli+HAL,
80 nM folimycin and 10 mM HAL).
(F) Normalized average Df values of fluo-4 amplitudes
relative to the DMSO (n = 2 experiments) control (n = 3–5
experiments, n > 500 synapses). Error bars represent
SEM. ***p < 0.001, t tests. n. s., not significant.
See Figure S5.
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(p < 0.05) reduced, while the administration of folimycin alone did
not affect exocytosis (Figure S5; Sankaranarayanan and Ryan,
2001).
To measure this effect with another pH-independent optical
probe, we repeated the experiment with the Ca2+-sensitive dye
fluo-4 (Figure 8D). Again, electrical stimulation resulted in
a marked increase in fluo-4 fluorescence, which was reduced
upon HAL (5 mM) application (Figure 8E). In agreement with the
FM experiments described in the previous paragraph, folimycin
application significantly decreased the reduction of the fluo-4840 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.amplitude induced by HAL (Figure 8F). Thus,
the accumulation of APDs in synaptic vesicles
significantly contributes to their inhibitory
effects on synaptic vesicle exocytosis.
DISCUSSION
During treatment, APDs and other psychotropic
drugs accumulate in the brains of patients. In
the present work, we studied the subcellular
localization of APD accumulation in acidic
organelles and identified functional conse-
quences of this phenomenon. We demon-
strated that accumulated APDs are secreted
from synaptic vesicles upon exocytosis, leading
to increased extracellular drug concentrations
during neuronal activity. The secretion of APDsin turn was able to inhibit synaptic transmission in a use-depen-
dent manner.
Increase of Extracellular Concentrations
by Activity-Dependent Secretion of APDs
We found that synaptic transmission as measured by synaptic
vesicle exocytosis was reduced by APDs in low micromolar
concentrations. This concentration range raised our concerns
because it has been convincingly demonstrated that the clinical
efficacy of APDs correlates with effects observed for nanomolar
concentrations (Seeman et al., 1976). Additionally, APDs acutely
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(Figure 6), which in previous work were found unlikely to be
achieved extracellularly during APD therapy (Baumann et al.,
2004). Thus, instead of therapeutic benefits, continuously
present micromolar APD concentrations were related mainly to
side effects of the drugs (Ogata et al., 1989).
A major part of our study was, therefore, devoted to demon-
strate that the accumulation of APDs in synaptic vesicles (Table
1; Figures 1 and 2) results in high APD concentrations within
these confined compartments. Upon activity, synapses release
their micromolar APD content into the synaptic cleft (Figure 3).
We confirmed the activity-dependent release by in vitro fluores-
cence microscopy and in vivo data from experiments with freely
moving rats treated with HAL. The released APDs have an inhib-
itory effect on signal propagation by promoting sodium channel
inactivation (Figures 6 and 7). Even the extracellular HAL con-
centrations in the nanomolar range were sufficient to exert
a use-dependent inhibitory action under prolonged stimulation
(Figures 6 and 7). Accordingly, APD concentrations inhibiting
sodium channels are likely to be reached at least locally during
neuronal activity. Overall, both inhibition of sodium channels
and activity-dependent secretion contribute to the use-depen-
dent action of the drugs. The present work, thus, suggests
a mechanism wherein the presence of APDs in synaptic vesicles
results in increased extracellular APD concentrations upon
neuronal activity, leading to autoinhibitory feedback on synaptic
transmission.
Potential Implications of APD Accumulation
and Secretion Affecting the Understanding
of Therapeutic Actions of APDs
While the therapeutic effect of APDs starts soon after applica-
tion, it usually reaches its maximum after 4–6 weeks (Agid
et al., 2003; Leucht et al., 2005). The effects on synaptic trans-
mission reported here, which are based on the accumulation of
the drugs, might contribute to the slow development of the full
therapeutic action of the drugs because tissue accumulation
occurs within the same time range (Kornhuber et al., 1999).
Accordingly, accumulation and secretion effects could explain
the beneficial effects of electroconvulsive therapy (ECT) during
APD treatment, which are not observed when ECT is performed
without APD therapy (Falkai et al., 2005). In light of our findings
(Figures 3 and 4), the concentration of APDs available locally is
likely to be increased acutely upon ECT-induced seizures.
Physiologically, precisely mediated negative feedback inhibi-
tion of neocortical pyramidal cells is necessary for the generation
of synchronized high-frequency oscillations, which are related to
attention and perception, and whose disturbance has been
linked to the pathophysiology of schizophrenia (Uhlhaas and
Singer, 2010). Such a deficit in synchronization has, for example,
been found in psychotic patients prior to antipsychotic treatment
(Gallinat et al., 2004) and chronically ill patients (Ferrarelli et al.,
2010; Uhlhaas et al., 2006).
The autoinhibition of synaptic transmission described here
by the secretion of accumulated APDs could be beneficial
to the generation of synchronized neuronal oscillations in
schizophrenia. Our data underline the importance of measuring
the neuronal oscillation patterns of unmedicated patients, orpatients free of symptoms after sufficient antipsychotic therapy
and in an already accumulated drug state. If the secretion of
APDs and the associated selective modulation of synaptic
transmission were important for the treatment of schizophrenia,
then one could further speculate that an enriched environment
(Oshima et al., 2003; Tost and Meyer-Lindenberg, 2012) is useful
for patients under medication, whereas it would harm the
psychotic, not yet treated patient.
Concluding Remarks
Taken together, our study proves the concept of APD accumula-
tion first suggested by Rayport and Sulzer (1995) and defines
synaptic vesicles as organelles that exert accumulation- and
use-dependent inhibitory functional effects. Although we found
more pronounced inhibitory effects of APDs in striatal tissue
(Figure 7), which hosts the receptors that bind the drugs in nano-
molar concentrations (in this case DA receptors), our current
results are limited with respect to other substance classes or
synapse types. It will therefore be interesting to investigate the
autoinhibitory effects of psychotropic drugs accumulated in
synaptic vesicles on specific network activity profiles within
cortical (Goto et al., 2010) and subcortical (Kellendonk, 2009)
pathways as well as various neurotransmitter systems (Lisman
et al., 2008), especially DA signaling, and differential effects of
other classes of psychotropic drugs (Sulzer, 2011).
EXPERIMENTAL PROCEDURES
Ethics Statement
All animal work was approved by the Kollegiales Leitungsgremium of the
Franz-Penzoldt Zentrum, Erlangen and was conducted in conformity with
the Animal Protection Law of the Federal Republic of Germany and the guide-
lines of the State of Bavaria.
Cell Culture and Transfection
Hippocampal neuronal cultures were prepared from 1- to 4-day-old Wistar
rats. Briefly, newborn rats were sacrificed by decapitation. The hippocampus
was removed from each brain and was transferred into ice-cold Hank’s
salt solution, and the dentate gyrus was cut away. After digestion with
trypsin (5 mg ml1), cells were triturated mechanically and plated in MEM,
supplemented with 10% fetal calf serum and 2% B27 Supplement (all from In-
vitrogen, Taufkirchen, Germany). If required, neurons were transfected on
DIV3 (days in vitro) with spH (Sankaranarayanan et al., 2000) under the control
of a synapsin promoter with a modified calcium phosphate method by
Threadgill et al. (1997). Experiments were performed between DIV25 and
DIV30.
N1E115 neuroblastoma cells were maintained at 37C in 5% CO2 in DMEM
(Invitrogen) with 5 g/l glucose and were supplemented with 10% fetal bovine
serum (Biochrom, Berlin) and 1% penicillin/streptomycin solution (Biochrom).
Cells were trypsinized and plated in 3.5 cm dishes (Corning, Lowell, MA, USA).
For recordings from NaV1.6r, N1E115 cells were transfected on the next day
with 1 mg of cDNA for each dish and 0.5 mg of pEGFP-C1 (Mountain View,
CA, USA) with Nanofectin (PAA, Pasching, Austria) according to the manufac-
turers’ protocol. The mNaV1.6 was a gift from E. Leipold and S. Heinemann
(Leipold et al., 2006). The TTX-resistant variant mNaV1.6r Y371S was con-
structed with the use of the QuikChange II XL Site-Directed Mutagenesis Kit
(Agilent Technologies, Santa Clara, CA, USA).
Imaging
Experiments were conducted at room temperature on a Nikon TI-Eclipse
inverted microscope (603, 1.2 NA water-immersion objective; Perfect Focus
System). Fluorescence was excited by a Nikon Intensilight C-HGFI through
excitation filters centered at 482, 561, and 628 nm using dichroic long-passNeuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc. 841
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light passed emission band-pass filters ranging from 500 to 550 nm, 570
to 640 nm, and 660 to 730 nm (Semrock, Rochester, NY, USA) and was pro-
jected onto a cooled EM-CCD camera (iXonEM DU-885 or iXonEM DU-897;
Andor).
Coverslips were placed into a perfusion chamber. Please see the Supple-
mental Experimental Procedures for a description of solutions, dyes, anti-
bodies, and inhibitors for the individual experiments. Throughout the experi-
ments, perfusion was kept constantly at 0.2 ml/min (Fast-Step Valve Control
Perfusion System VC-77SP8; Warner Instruments). Fast solution exchanges
were achieved by a piezo-controlled stepper device (SF-77B; Warner Instru-
ments) using a three-barrel glass tubing. Synaptic boutons were stimulated
by electric field stimulation (platinum electrodes, 10 mm spacing, 1 ms pulses
of 50 mA and alternating polarity).
Recorded image stacks were used to automatically detect spots of synaptic
bouton size (Sbalzarini and Koumoutsakos, 2005), where an electrically
evoked fluorescence increase (spH and fluo-4) or decrease (FM dyes)
occurred in difference images. For LTR DND-99 (Invitrogen, Karlsruhe) exper-
iments, synapses labeled with an anti-Synaptotagmin1 antibody were de-
tected by a Laplace-operator-based peak detection method by Dorostkar
et al. (2010). All image and data analysis was performed using custom-written
routines in MATLAB (The MathWorks, Natick, MA, USA). SpH and fluo-4 fluo-
rescence was normalized to the mean stimulation-dependent difference in
fluorescence (DF) before drug application.
Photoconversion and Electron Microscopy
Rat hippocampal neurons were incubated with 500 nM LTR for 1 hr at 37C
and subsequently fixed in 2.5% glutaraldehyde in PBS. Illumination for the
photoconversion of LTR was performed through a 203 0.5 NA objective
(Olympus, Hamburg, Germany) with green light (550 nm) for 45–60 min in the
presence of a 1.5 mg/ml DAB solution. Photoconversion of FM1-43 and further
electron microscope processing followed a standard protocol by Denker et al.
(2009).
Electrophysiology
Transverse slices containing hippocampus and coronal slices containing NAc
(350 mm thick) were prepared from 1-month-old rats. Electrophysiological
signals were filtered at 1 kHz and sampled at 10 kHz using a MultiClamp
700B amplifier in conjunction with a Digidata 1440A interface and pClamp10
software (all fromMolecular Devices, Sunnyvale, CA, USA). Whole-cell record-
ings of visualized CA1 pyramidal cells and NAc medium spiny neurons were
performed in artificial cerebrospinal fluid (aCSF, see Supplemental Experi-
mental Procedures). Patch pipettes were filled with 135 mM K-gluconate,
5 mM HEPES, 3 mM MgCl2, 5 mM EGTA, 2 mM Na2ATP, 0.3 mM NaGTP,
and 4 mM NaCl (pH 7.3). Constant current pulses (pulse width 0.1 ms,
60–400 mA) were delivered to a concentric bipolar tungsten-stimulating elec-
trode positioned in CA1 stratum radiatum and in NAc to evoke synaptic
currents in pyramidal cells and NAc neurons, respectively. Glutamatergic
EPSCs were recorded at 80mV (after correcting liquid junction potentials)
and were pharmacologically isolated by perfusing slices with picrotoxin
(100 mM), APV (50 mM), and CGP 55845 (2 mM). Field potentials arising from
axonal action potentials (FVs) were evoked by a bipolar electrode (pulse width
0.1 ms) and were recorded in CA1 stratum radiatum or NAc with extracellular
recording pipettes filled with modified aCSF (in which bicarbonate was
replaced with HEPES to avoid a pH change). Synaptic responses were
abrogated by a combination of low-calcium aCSF (0.5 mM CaCl2, 3.5 mM
MgCl2), picrotoxin, and the ionotropic glutamate receptor antagonist kynur-
enic acid (2 mM).
In neuroblastoma N1E115 cells transfected with a TTX-resistant Nav1.6,
sodium currents carried by the TTX-resistant Nav1.6r mutant were isolated
by adding 1 mM TTX (Biotrend, Wangen/Zurich, Switzerland) to the bath.
Current signals were recorded in whole-cell voltage-clamp mode at room
temperature (21C ± 1C). Recordings were sampled at 20 kHz (low-pass filter
5 kHz) using an Axopatch 200A amplifier in conjunction with a Digidata 1322A
interface and pClamp10 software. For details on the measurement protocols
and the solutions used, please refer to the Supplemental Experimental
Procedures.842 Neuron 74, 830–844, June 7, 2012 ª2012 Elsevier Inc.Microdialysis
Guide cannulae (MAB6.14, Microbiotech) were implanted into male Sprague-
Dawley rats targeting the medial PFC, caudate-putamen, and NAc, as
described in Pum et al. (2008). After 5–6 days of recovery, osmotic minipumps
(Samaha et al., 2007) were implanted and used to deliver HAL (0.5 mg/kg/d;
i.p.) over a period of 14 days. During the experiments a 100 mM K+ challenge
was applied for 80 min by reverse dialysis, before the perfusion medium was
changed back to aCSF. HAL analysis was performed by LC-MS/MS with
online extraction. DA and 5-HT analysis was performed by high-performance
liquid chromatography with electrochemical detection (Pum et al., 2008).
Cell Model of APD Accumulation
The accumulation of APDs in synaptic vesicles was assessed using a mathe-
matical model based on the Fick-Nernst-Planck equation (Trapp et al., 2008)
(Zhang et al., 2010), as described in detail in the Supplemental Experimental
Procedures. Properties of the test compounds given in Table 1 were estimated
using ACD (ACD/LogD Suite version 10.04, 2007; Advanced Chemistry Devel-
opment, Toronto), and therapeutic plasma levels for CPZ, HAL, CLO, and RSP
were taken from Baumann et al. (2004).
Statistical Analysis
Statistical analysis was performed using MATLAB. Error bars indicate SEM
unless otherwise indicated. To analyze the effects of treatment, ANOVA was
used. For single-group comparisons, unpaired t tests were applied. These
tests were performed using built-in routines in MATLAB.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2012.04.019.
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